Neutrophil Gelatinase Associated Lipocalin in Acute Kidney Injury

Postgraduate Medicine

Volumn 125, Issue 6, 2013, Pages 82-93

  iv, W Frank Peacock ^a,b   Maisel, Alan ^c   Kim, Jieun ^d   Ronco, Claudio ^e  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b BEN TAUB GENERAL HOSPITAL   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e SAN BORTOLO HOSPITAL   (Italy)

Author keywords

acute kidney injury; neutrophil gelatinase associated lipocalin; renal dysfunction; renal failure

Indexed keywords

ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

ACUTE KIDNEY FAILURE; BLOOD; CARDIOVASCULAR DISEASE; CRITICAL ILLNESS; EMERGENCY HEALTH SERVICE; HEART SURGERY; HUMAN; INTENSIVE CARE UNIT; METABOLISM; NEPHROLOGY; PATHOPHYSIOLOGY; REVIEW;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; BIOLOGICAL MARKERS; CARDIAC SURGICAL PROCEDURES; CARDIOVASCULAR DISEASES; CRITICAL ILLNESS; EMERGENCY SERVICE, HOSPITAL; HUMANS; INTENSIVE CARE UNITS; LIPOCALINS; NEPHROLOGY; PROTO-ONCOGENE PROTEINS;

EID: 84891689841     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2013.11.2715     Document Type: Article

References (204)

1. Supavekin S, Zhang W, Kucherlapati R, Kaskel FJ, Moore LC, Devarajan P. Differential gene expression following early renal ischemia/reperfusion. Kidney Int. 2003; 63 (5): 1714 – 1724
2. Mishra J, Mori K, Ma Q, Kelly C, Barasch J, Devarajan P. Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol. 2004; 24 (3): 307 – 315
3. Mori K, Lee HT, Rapoport D,. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest. 2005; 115 (3): 610 – 621
4. Schmidt-Ott KM, Mori K, Li JY,. Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol. 2007; 18 (2): 407 – 413
5. Mori K, Nakao K. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int. 2007; 71 (10): 967 – 970
6. Hirsch R, Dent C, Pfriem H,. NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol. 2007; 22 (12): 2089 – 2095
7. Mishra J, Dent C, Tarabishi R,. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005; 365 (9466): 1231 – 1238
8. Shapiro NI, Trzeciak S, Hollander JE,. The diagnostic accuracy of plasma neutrophil gelatinase-associated lipocalin in the prediction of acute kidney injury in emergency department patients with suspected sepsis. Ann Emerg Med. 2010; 56 (1): 52 – 59, el
9. Aghel A, Shrestha K, Mullens W, Borowski A, Tang WH. Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure. J Card Fail. 2010; 16 (1): 49 – 54
10. Devarajan P. Emerging biomarkers of acute kidney injury. Contrib Nephrol. 2007; 156: 203 – 212
11. Wu Y, Su T, Yang L, Zhu SN, Li XM. Urinary neutrophil gelatinase-associated lipocalin: a potential biomarker for predicting rapid progression of drug-induced chronic tubulointerstitial nephritis. Am J Med Sci. 2010; 339 (6): 537 – 542
12. Vaidya VS, Waikar SS, Ferguson MA,. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci. 2008; 1 (3): 200 – 208
13. NGAL Rapid ELISA Kit (KIT 037) [package insert]. Gentofte, Denmark: BioPorto Diagnostics A/S; 2010. http://ngal.com/media/52188/kit_037_ifu_ruo.pdf. Accessed October 21, 2012
14. Nickolas TL, O'Rourke MJ, Yang J,. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med. 2008; 148 (11): 810 – 819
15. Kusaka M, Kuroyanagi Y, Mori T,. Serum neutrophil gelatinase-associated lipocalin as a predictor of organ recovery from delayed graft function after kidney transplantation from donors after cardiac death. Cell Transplant. 2008; 17 (1–2): 129 – 134
16. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, Malyszko JS, Dobrzycki S. Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions. Am J Nephrol. 2006; 26 (3): 287 – 292
17. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E,. NGAL (neutrophil gelatinase-associated lipocalin) and cystatin C: are they good predictors of contrast nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine? Int J Cardiol. 2008; 127 (2): 290 – 291
18. Trachtman H, Christen E, Cnaan A,; Investigators of the HUS-SYNSORB Pk Multicenter Clinical Trial. Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injury. Pediatr Nephrol. 2006; 21 (7): 989 – 994
19. Wagener G, Jan M, Kim M,. Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology. 2006; 105 (3): 485 – 491
20. Brunner HI, Mueller M, Rutherford C,. Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus. Arthritis Rheum. 2006; 54 (8): 2577 – 2584
21. Bolignano D, Coppolino G, Campo S,. Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease. Am J Nephrol. 2007; 27 (4): 373 – 378
22. Bolignano D, Coppolino G, Campo S,. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients. Nephrol Dial Transplant. 2008; 23 (1): 414 – 416
23. Ding H, He Y, Li K,. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Clin Immunol. 2007; 123 (2): 227 – 234
24. Thrailkill KM, Moreau CS, Cockrell GE,. Disease and gender-specific dysregulation of NGAL and MMP-9 in type 1 diabetes mellitus. Endocrine. 2010; 37 (2): 336 – 343
25. Ferguson MA, Vaidya VS, Waikar SS,. Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury. Kidney Int. 2010; 77 (8): 708 – 714
26. Yilmaz A, Sevketoglu E, Gedikbasi A,. Early prediction of urinary tract infection with urinary neutrophil gelatinase associated lipocalin. Pediatr Nephrol. 2009; 24 (12): 2387 – 2392
27. Paragas N, Nickolas TL, Wyatt C,. Urinary NGAL marks cystic disease in HIV-associated nephropathy. J Am Soc Nephrol. 2009; 20 (8): 1687 – 1692
28. Wheeler DS, Devarajan P, Ma Q,. Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock. Crit Care Med. 2008; 36 (4): 1297 – 1303
29. Zappitelli M, Washburn KK, Arikan AA,. Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study. Crit Care. 2007; 11 (4): R84
30. Nishida M, Kawakatsu H, Okumura Y, Hamaoka K. Serum and urinary neutrophil gelatinase-associated lipocalin levels in children with chronic renal diseases. Pediatr Int. 2010; 52 (4): 563 – 568
31. Malyszko J, Bachorzewska-Gajewska H, Poniatowski B, Malyszko JS, Dobrzycki S. Urinary and serum biomarkers after cardiac catheterization in diabetic patients with stable angina and without severe chronic kidney disease. Ren Fail. 2009; 31 (10): 910 – 919
32. Meijer E, Boertien WE, Nauta FL,. Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis. Am J Kidney Dis. 2010; 56 (5): 883 – 895
33. Przybylowski P, Malyszko J, Malyszko JS. Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in heart allograft recipients. Transplant Proc. 2010; 42 (5): 1797 – 1802
34. Ramesh G, Kwon O, Ahn K. Netrin-1: a novel universal biomarker of human kidney injury. Transplant Proc. 2010; 42 (5): 1519 – 1522
35. Perry TE, Muehlschlegel JD, Liu KY,; CABG Genomics Investigators. Plasma neutrophil gelatinase-associated lipocalin and acute postoperative kidney injury in adult cardiac surgical patients. Anesth Analg. 2010; 110 (6): 1541 – 1547
36. Mårtensson J, Bell M, Oldner A, Xu S, Venge P, Martling CR. Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury. Intensive Care Med. 2010; 36 (8): 1333 – 1340
37. Kümpers P, Hafer C, Lukasz A,. Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury. Crit Care. 2010; 14 (1): R9
38. Cruz DN, de Cal M, Garzotto F,. Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med. 2010; 36 (3): 444 – 451
39. Bagshaw SM, Bennett M, Haase M,. Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness. Intensive Care Med. 2010; 36 (3): 452 – 461
40. Niemann CU, Walia A, Waldman J,. Acute kidney injury during liver transplantation as determined by neutrophil gelatinase-associated lipocalin. Liver Transpl. 2009; 15 (12): 1852 – 1860
41. Szewczyk M, Wielkoszyhski T, Zakliczyhski M, Zembala M. Plasma neutrophil gelatinase-associated lipocalin (NGAL) correlations with cystatin C, serum creatinine, and glomerular filtration rate in patients after heart and lung transplantation. Transplant Proc. 2009; 41 (8): 3242 – 3243
42. Constantin JM, Futier E, Perbet S,. Plasma neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in adult critically ill patients: a prospective study. J Crit Care. 2010; 25 (1): 176, e1–6
43. Hall IE, Yarlagadda SG, Coca SG,. IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. J Am Soc Nephrol. 2010; 21 (1): 189 – 197
44. Malyszko J, Malyszko JS, Mysliwiec M. Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in renal allograft recipients. Clin Transplant. 2009; 23 (5): 681 – 686
45. Capuano F, Goracci M, Luciani R,. Neutrophil gelatinase-associated lipocalin levels after use of mini-cardiopulmonary bypass system. Interact Cardiovasc Thorac Surg. 2009; 9 (5): 797 – 801
46. Siew ED, Ware LB, Gebretsadik T,. Urine neutrophil gelatinase-associated lipocalin moderately predicts acute kidney injury in critically ill adults. J Am Soc Nephrol. 2009; 20 (8): 1823 – 1832
47. Liangos O, Tighiouart H, Perianayagam MC,. Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass. Biomarkers. 2009; 14 (6): 423 – 431
48. Haase M, Bellomo R, Devarajan P,. Novel biomarkers early predict the severity of acute kidney injury after cardiac surgery in adults. Ann Thorac Surg. 2009; 88 (1): 124 – 130
49. Haase-Fielitz A, Bellomo R, Devarajan P,. The predictive performance of plasma neutrophil gelatinase-associated lipocalin (NGAL) increases with grade of acute kidney injury. Nephrol Dial Transplant. 2009; 24 (11): 3349 – 3354
50. Han WK, Wagener G, Zhu Y, Wang S, Lee HT. Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery. Clin J Am Soc Nephrol. 2009; 4 (5): 873 – 882
51. Cai L, Borowiec J, Xu S, Han W, Venge P. Assays of urine levels of HNL/NGAL in patients undergoing cardiac surgery and the impact of antibody configuration on their clinical performances. Clin Chim Acta. 2009; 403 (1–2): 121 – 125
52. Poniatowski B, Malyszko J, Bachorzewska-Gajewska H, Malyszko JS, Dobrzycki S. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in patients with chronic heart failure and coronary artery disease. Kidney Blood Press Res. 2009; 32 (2): 77 – 80
53. Malyszko J, Malyszko JS, Bachorzewska-Gajewska H, Poniatowski B, Dobrzycki S, Mysliwiec M. Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients. Transplant Proc. 2009; 41 (1): 158 – 161
54. Tuladhar SM, Püntmann VO, Soni M, Punjabi PP, Bogle RG. Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass. J Cardiovasc Pharmacol. 2009; 53 (3): 261 – 266
55. Wagener G, Gubitosa G, Wang S, Borregaard N, Kim M, Lee HT. A comparison of urinary neutrophil gelatinase-associated lipocalin in patients undergoing on- versus off-pump coronary artery bypass graft surgery. J Cardiothorac Vase Anesth. 2009; 23 (2): 195 – 199
56. Bolignano D, Lacquaniti A, Coppolino G,. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol. 2009; 4 (2): 337 – 344
57. Haase-Fielitz A, Bellomo R, Devarajan P,. Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery-a prospective cohort study. Crit Care Med. 2009; 37 (2): 553 – 560
58. Wagener G, Gubitosa G, Wang S, Borregaard N, Kim M, Lee HT. Urinary neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery. Am J Kidney Dis. 2008; 52 (3): 425 – 433
59. Bolignano D, Lacquaniti A, Coppolino G, Campo S, Arena A, Buemi M. Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease. Kidney Blood Press Res. 2008; 31 (4): 255 – 258
60. Ling W, Zhaohui N, Ben H,. Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography. Nephron Clin Pract. 2008; 108 (3): c176 – 181
61. Malyszko J, Bachorzewska-Gajewska H, Malyszko JS, Pawlak K, Dobrzycki S. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease. Nephrology (Carlton). 2008; 13 (2): 153 – 156
62. Wagener G, Gubitosa G, Wang S, Borregaard N, Kim M, Lee HT. Increased incidence of acute kidney injury with aprotinin use during cardiac surgery detected with urinary NGAL. Am J Nephrol. 2008; 28 (4): 576 – 582
63. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E,. Could neutrophil-gelatinase-associated lipocalin and cystatin C predict the development of contrast-induced nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine values? Kidney Blood Press Res. 2007; 30 (6): 408 – 415
64. Parikh CR, Mishra J, Thiessen-Philbrook H,. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int. 2006; 70 (1): 199 – 203
65. Schaub S, Nickerson P, Rush D,. Urinary CXCL9 and CXCL10 levels correlate with the extent of subclinical tubulitis. Am J Transplant. 2009; 9 (6): 1347 – 1353
66. Zhao C, Ozaeta P, Fishpaugh J,. Structural characterization of glycoprotein NGAL, an early predictive biomarker for acute kidney injury. Carbohydr Res. 2010; 345 (15): 2252 – 2261
67. Haase M, Devarajan P, Haase-Fielitz A,. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J Am Coll Cardiol. 2011; 57 (17): 1752 – 1761
68. Nickolas TL, Schmidt-Ott KM, Canetta P,. Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study. J Am Coll Cardiol. 2012; 59 (3): 246 – 255
69. Parikh CR, Coca SG, Thiessen-Philbrook H,; TRIBE-AKI Consortium. Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Neph. 2011; 22 (9): 1748 – 1757
70. Parikh CR, Devarajan P, Zappitelli M,; TRIBE-AKI Consortium. Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery. J Am Soc Nephrol. 2011; 22 (9): 1737 – 1747
71. Pedersen KR, Ravn HB, Povlsen JV, Schmidt MR, Erlandsen EJ, Hjortdal VE. Failure of remote ischemic preconditioning to reduce the risk of postoperative acute kidney injury in children undergoing operation for complex congenital heart disease: a randomized single-center study. J Thorac Cardiovasc Surg. 2012; 143 (3): 576 – 583
72. Srisawat N, Murugan R, Lee M,; Genetic and Inflammatory Markers of Sepsis (GenIMS) Study Investigators. Plasma neutrophil gelatinase-associated lipocalin predicts recovery from acute kidney injury following community-acquired pneumonia. Kidney Int. 2011; 80 (5): 545 – 552
73. Srisawat N, Wen X, Lee M,. Urinary biomarkers and renal recovery in critically ill patients with renal support. Clin J Am Soc Nephrol. 2011; 6 (8): 1815 – 1823
74. Przybylowski P, Malyszko J, Malyszko J. Kidney function assessed by eGFR, cystatin C and NGAL (neutrophil gelatinase-associated lipocalin) in relation to age in heart allograft recipients. Med Sci Monit. 2010; 16 (9): CR440 – 444
75. McIlroy DR, Wagener G, Lee HT. Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance. Clin J Am Soc Nephrol. 2010; 5 (2): 211 – 219
76. Boldt J, Suttner S, Brosch C, Lehmann A, Röhm K, Mengistu A. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy. Anesth Analg. 2009; 109 (6): 1752 – 1762
77. Cruz DN, Soni S, Ronco C. NGAL and cardiac surgery-associated acute kidney injury [commentary]. Am J Kidney Dis. 2009; 53 (3): 565 – 566; author reply 566
78. Haase M, Haase-Fielitz A, Bellomo R,. Sodium bicarbonate to prevent increases in serum creatinine after cardiac surgery: a pilot double-blind, randomized controlled trial. Crit Care Med. 2009; 37 (1): 39 – 47
79. Boldt J, Brosch Ch, Röhm K, Lehmann A, Mengistu A, Suttner S. Is albumin administration in hypoalbuminemic elderly cardiac surgery patients of benefit with regard to inflammation, endothelial activation, and long-term kidney function? Anesth Analg. 2008; 107 (5): 1496 – 1503
80. Boldt J, Suttner S, Brosch C, Lehmann A, Röhm K, Mengistu A. The influence of a balanced volume replacement concept on inflammation, endothelial activation, and kidney integrity in elderly cardiac surgery patients. Intensive Care Med. 2009; 35 (3): 462 – 470
81. Bennett M, Dent CL, Ma Q,. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol. 2008; 3 (3): 665 – 673
82. Boldt J, Brosch Ch, Röhm K, Papsdorf M, Mengistu A. Comparison of the effects of gelatin and a modern hydroxyethyl starch solution on renal function and inflammatory response in elderly cardiac surgery patients. Br J Anaesth. 2008; 100 (4): 457 – 464
83. Aström-Olsson K, Hedström E, Hultén LM,. Dissociation of the inflammatory reaction following PCI for acute myocardial infarction. J Invasive Cardiol. 2007; 19 (11): 452 – 456
84. Boldt J, Brosch C, Ducke M, Papsdorf M, Lehmann A. Influence of volume therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin. Crit Care Med. 2007; 35 (12): 2740 – 2746
85. Jönsson P, Ståhl ML, Ohlsson K. Extracorporeal circulation causes release of neutrophil gelatinase-associated lipocalin (NGAL). Mediators Inflamm. 1999; 8 (3): 169 – 171
86. Choi YS, Shim JK, Kim JC,. Effect of remote ischemic preconditioning on renal dysfunction after complex valvular heart surgery: a randomized controlled trial. J Thorac Cardiovasc Surg. 2011; 142 (1): 148 – 154
87. Damman K, Van Veldhuisen DJ, Navis G,. Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate. Heart. 2010; 96 (16): 1297 – 1302
88. Zografos T, Haliassos A, Korovesis S, Giazitzoglou E, Voridis E, Katritsis D. Association of neutrophil gelatinase-associated lipocalin with the severity of coronary artery disease. Am J Cardiol. 2009; 104 (7): 917 – 920
89. Damman K, van Veldhuisen DJ, Navis G, Voors AA Hillege HL. Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure. Eur J Heart Fail. 2008; 10 (10): 997 – 1000
90. Giaginis C, Zira A, Katsargyris A, Klonaris C, Theocharis S. Clinical implication of plasma neutrophil gelatinase-associated lipocalin (NGAL) concentrations in patients with advanced carotid atherosclerosis. Clin Chem Lab Med. 2010; 48 (7): 1035 – 1041
91. Maisel AS, Mueller C, Fitzgerald R,. Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial. Eur J Heart Fail. 2011; 13 (8): 846 – 851
92. Shapiro NI, Trzeciak S, Hollander JE,. A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis. Crit Care Med. 2009; 37 (1): 96 – 104
93. Porta C, Paglino C, De Amici M,. Predictive value of baseline serum vascular endothelial growth factor and neutrophil gelatinase-associated lipocalin in advanced kidney cancer patients receiving sunitinib. Kidney Int. 2010; 77 (9): 809 – 815
94. Rubinstein T, Pitashny M, Levine B,. Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis. Rheumatology (Oxford). 2010; 49 (5): 960 – 971
95. Malyszko J, Malyszko JS, Koc-Zorawska E, Kozminski P, Mysliwiec M. Neutrophil gelatinase-associated lipocalin in dialyzed patients is related to residual renal function, type of renal replacement therapy and inflammation. Kidney Blood Press Res. 2009; 32 (6): 464 – 469
96. Hinze CH, Suzuki M, Klein-Gitelman M,. Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity. Arthritis Rheum. 2009; 60 (9): 2772 – 2781
97. Huynh TK, Bateman DA, Parravicini E,. Reference values of urinary neutrophil gelatinase-associated lipocalin in very low birth weight infants. Pediatr Res. 2009; 66 (5): 528 – 532
98. Yang YH, He XJ, Chen SR, Wang L, Li EM, Xu LY. Changes of serum and urine neutrophil gelatinase-associated lipocalin in type-2 diabetic patients with nephropathy: one year observational follow-up study. Endocrine. 2009; 36 (1): 45 – 51
99. Bolignano D, Lacquaniti A, Coppolino G,. Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. Kidney Blood Press Res. 2009; 32 (2): 91 – 98
100. Malyszko J, Bachorzewska-Gajewska H, Sitniewska E, Malyszko JS, Poniatowski B, Dobrzycki S. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2–4 chronic kidney disease. Ren Fail. 2008; 30 (6): 625 – 628
101. Suzuki M, Wiers KM, Klein-Gitelman MS,. Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis. Pediatr Nephrol. 2008; 23 (3): 403 – 412
102. Sundaram N, Bennett M, Wilhelm J,. Biomarkers for early detection of sickle nephropathy. Am J Hematol. 2011; 86 (7): 559 – 566
103. Ibernon M, Moreso F, Moreno JM,. Low serum mannose-binding lectin as a risk factor for new onset diabetes mellitus after renal transplantation. Transplantation. 2009; 88 (2): 272 – 278
104. Lebkowska U, Malyszko J, Lebkowska A,. Neutrophil gelatinase-associated lipocalin and cystatin C could predict renal outcome in patients undergoing kidney allograft transplantation: a prospective study. Transplant Proc. 2009; 41 (1): 154 – 157
105. Lollike K, Kjeldsen L, Sengeløv H, Borregaard N. Lysozyme in human neutrophils and plasma. A parameter of myelopoietic activity. Leukemia. 1995; 9 (1): 159 – 164
106. Marti J, Fuster J, Hotter G,. Serum neutrophil gelatinase-associated lipocalin in patients with colorectal liver metastases: preliminary results of an exploratory prospective study. Int J Biol Markers. 2010; 25 (1): 21 – 26
107. Mishra J, Ma Q, Kelly C,. Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol. 2006; 21 (6): 856 – 863
108. Oberbauer R. Biomarkers-a potential route for improved diagnosis and management of ongoing renal damage. Transplant Proc. 2008; 40 (10 suppl): S44 – S47
109. Parikh CR, Jani A, Mishra J,. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant. 2006; 6 (7): 1639 – 1645
110. Portal AJ, McPhail MJ, Bruce M,. Neutrophil gelatinase-associated lipocalin predicts acute kidney injury in patients undergoing liver transplantation. Liver Transpl. 2010; 16 (11): 1257 – 1266
111. Schaub S, Mayr M, Hönger G,. Detection of subclinical tubular injury after renal transplantation: comparison of urine protein analysis with allograft histopathology Transplantation. 2007; 84 (1): 104 – 112
112. Gaspari F, Cravedi P, Mandalà M,. Predicting cisplatin-induced acute kidney injury by urinary neutrophil gelatinase-associated lipocalin excretion: a pilot prospective case-control study. Nephron Clin Pract. 2010; 115 (2): c154 – 160
113. Bagshaw SM, George C, Bellomo R; ANZICS Database Management Committee. A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients. Nephrol Dial Transplant. 2008; 23 (5): 1569 – 1574
114. Bagshaw SM, Uchino S, Bellomo R,; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol. 2007; 2 (3): 431 – 439
115. Neveu H, Kleinknecht D, Brivet F, Loirat P, Landais P. Prognostic factors in acute renal failure due to sepsis: results of a prospective multicentre study. The French Study Group on Acute Renal Failure. Nephrol Dial Transplant. 1996; 11 (2): 293 – 299
116. Lopes JA, Jorge S, Resina C,. Acute kidney injury inpatients with sepsis: a contemporary analysis. Int J Infect Dis. 2009; 13 (2): 176 – 181
117. Oppert M, Engel C, Brunkhorst FM,; German Competence Network Sepsis (Sepnet). Acute renal failure in patients with severe sepsis and septic shock-a significant independent risk factor for mortality: results from the German Prevalence Study. Nephrol Dial Transplant. 2008; 23 (3): 904 – 909
118. Uchino S, Kellum JA, Bellomo R,; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005; 294 (7): 813 – 818
119. Bagshaw SM, George C, Bellomo R; ANZICS Database Management Committee. Early acute kidney injury and sepsis: a multicentre evaluation. Crit Care. 2008; 12 (2): R47
120. Hoste EA, Lameire NH, Vanholder RC, Benoit DD, Decruyenaere JM, Colardyn FA. Acute renal failure in patients with sepsis in a surgical ICU: predictive factors, incidence, comorbidity, and outcome. J Am Soc Nephrol. 2003; 14 (4): 1022 – 1030
121. Yegenaga I, Hoste E, Van Biesen W,. Clinical characteristics of patients developing ARF due to sepsis/systemic inflammatory response syndrome: results of a prospective study. Am J Kidney Dis. 2004; 43 (5): 817 – 824
122. de Geus HR, Bakker J, Lesaffre EM, le Noble JL. Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients. Am J Respir Crit Care Med. 2011; 183 (7): 907 – 914
123. Makris K, Markou N, Evodia E,. Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients. Clin Chem Lab Med. 2009; 47 (1): 79 – 82
124. de Geus HR, Betjes MG, Bakker J. Neutrophil gelatinase-associated lipocalin clearance during veno-venous continuous renal replacement therapy in critically ill patients. Intensive Care Med. 2010; 36 (12): 2156 – 2157
125. Wang Y, Lam KS, Kraegen EW,. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem. 2007; 53 (1): 34 – 41
126. Yan QW, Yang Q, Mody N,. The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes. 2007; 56 (10): 2533 – 2540
127. Hemdahl AL, Gabrielsen A, Zhu C,. Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arterioscler Thromb Vase Biol. 2006; 26 (1): 136 – 142
128. Elneihoum AM, Falke P, Hedblad B, Lindgärde F, Ohlsson K. Leukocyte activation in atherosclerosis: correlation with risk factors. Atherosclerosis. 1997; 131 (1): 79 – 84
129. Yndestad A, Landrø L, Ueland T,. Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure. Eur Heart J. 2009; 30 (10): 1229 – 1236
130. Dent CL, Ma Q, Dastrala S,. Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care. 2007; 11 (6): R127
131. Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998; 104 (4): 343 – 348
132. Ghotkar SV, Grayson AD, Fabri BM, Dihmis WC, Pullan DM. Preoperative calculation of risk for prolonged intensive care unit stay following coronary artery bypass grafting. J Cardiothorac Surg. 2006; 1: 14
133. Stafford-Smith M, Podgoreanu M, Swaminathan M,; Perioperative Genetics and Safety Outcomes Study (PEGASUS) Investigative Team Association of genetic polymorphisms with risk of renal injury after coronary bypass graft surgery. Am J Kidney Dis. 2005; 45 (3): 519 – 530
134. Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest. 2004; 114 (1): 5 – 14
135. Garwood S. Renal insufficiency after cardiac surgery. Semin Cardiothorac Vasc Anesth. 2004; 8 (3): 227 – 241
136. Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet. 2005; 365 (9457): 417 – 430
137. Bove T, Calabrò MG, Landoni G,. The incidence and risk of acute renal failure after cardiac surgery. J Cardiothorac Vase Anesth. 2004; 18 (4): 442 – 445
138. Ho J, Lucy M, Krokhin O,. Mass spectrometry-based proteomic analysis of urine in acute kidney injury following cardiopulmonary bypass: a nested case-control study. Am J Kidney Dis. 2009; 53 (4): 584 – 595
139. Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization: The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med. 1998; 128 (3): 194 – 203
140. Lassnigg A, Schmidlin D, Mouhieddine M,. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004; 15 (6): 1597 – 1605
141. Loef BG, Epema AH, Smilde TD,. Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J Am Soc Nephrol. 2005; 16 (1): 195 – 200
142. Ryckwaert F, Boccara G, Frappier JM, Colson PH. Incidence, risk factors, and prognosis of a moderate increase in plasma creatinine early after cardiac surgery. Crit Care Med. 2002; 30 (7): 1495 – 1498
143. Zanardo G, Michielon P, Paccagnella A,. Acute renal failure in the patient undergoing cardiac operation: prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg. 1994; 107 (6): 1489 – 1495
144. Fortescue EB, Bates DW, Chertow GM. Predicting acute renal failure after coronary bypass surgery: cross-validation of two risk-stratification algorithms. Kidney Int. 2000; 57 (6): 2594 – 2602
145. Turtle KR, Worrall NK, Dahlstrom LR, Nandagopal R, Kausz AT, Davis CL. Predictors of ARF after cardiac surgical procedures. Am J Kidney Dis. 2003; 41 (1): 76 – 83
146. Mehta RH, Newby LK, Patel Y,; CRUSADE Investigators. The impact of emergency department structure and care processes in delivering care for non-ST-segment elevation acute coronary syndromes. Am Heart J. 2006; 152 (4): 648 – 660
147. Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006; 1 (1): 19 – 32
148. Murray PT, Le Gall JR, Dos Reis Miranda D, Pinsky MR, Tetta C. Physiologic endpoints (efficacy) for acute renal failure studies. Curr Opin Crit Care. 2002; 8 (6): 519 – 525
149. Rosner MH, Bolton WK. Renal function testing. Am J Kidney Dis. 2006; 47 (1): 174 – 183
150. Billings FT IV, Ball SK, Roberts LJ II, Pretorius M. Postoperative acute kidney injury is associated with hemoglobinemia and an enhanced oxidative stress response. Free Radic Biol Med. 2011; 50 (11): 1480 – 1487
151. Bolognese L, Falsini G, Schwenke C,. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial). Am J Cardiol. 2012; 109 (1): 67 – 74
152. Borzecki AM, Cevasco M, Chen Q, Shin M, Itani KM, Rosen AK. How valid is the AHRQ Patient Safety Indicator “postoperative physiologic and metabolic derangement”? J Am Coll Surg. 2011; 212 (6): 968 – 976, e1–2
153. Briguori C, Visconti G, Ricciardelli B, Condorelli G, REMEDIAL II Investigators. Renal insufficiency following contrast media administration trial II (REMEDIAL II): Renal Guard system in high-risk patients for contrast-induced acute kidney injury: rationale and design. Euro Intervention. 2011; 6 (9): 1117 – 1122
154. Clec'h C, Gonzalez F, Lautrette A,. Multiple-center evaluation of mortality associated with acute kidney injury in critically ill patients: a competing risks analysis. Crit Care. 2011; 15 (3): R128
155. Colpaert K, Hoste EA, Steurbaut K,. Impact of real-time electronic alerting of acute kidney injury on therapeutic intervention and progression of RIFLE class. Crit Care Med. 2012; 40 (4): 1164 – 1170
156. Haznedar R, Aki SZ, Akdemir OU,. Value of 18F-fluorodeoxyglucose uptake in positron emission tomography/computed tomography in predicting survival in multiple myeloma. Eur J Nucl Med Mol Imaging. 2011; 38 (6): 1046 – 1053
157. Jung JY, Park BH, Hong SB,. Acute kidney injury in critically ill patients with pandemic influenza A pneumonia 2009 in Korea: a multicenter study. J Crit Care. 2011; 26 (6): 577 – 585
158. Karkouti K, Wijeysundera DN, Yau TM,. Advance targeted transfusion in anemic cardiac surgical patients for kidney protection: an unblinded randomized pilot clinical trial. Anesthesiology. 2012; 116 (3): 613 – 621
159. Karlsberg RP, Dohad SY, Sheng R; Iodixanol Peripheral Computed Tomographic Angiography Study Investigator Panel. Contrast medium-induced acute kidney injury: comparison of intravenous and intraarterial administration of iodinated contrast medium. J Vase Interv Radiol. 2011; 22 (8): 1159 – 1165
160. Katagiri D, Doi K, Honda K,. Combination of two urinary biomarkers predicts acute kidney injury after adult cardiac surgery. Ann Thorac Surg. 2012; 93 (2): 577 – 583
161. Li S, Krawczeski CD, Zappitelli M,; TRIBE-AKI Consortium. Incidence, risk factors, and outcomes of acute kidney injury after pediatric cardiac surgery: a prospective multicenter study. Crit Care Med. 2011; 39 (6): 1493 – 1499
162. Li XM, Cong HL, Li TT, He LJ, Zhou YJ. Impact of benazepril on contrast-induced acute kidney injury for patients with mild to moderate renal insufficiency undergoing percutaneous coronary intervention. Chin Med J. 2011; 124 (14): 2101 – 2106
163. Libório AB, Abreu KL, Silva GB Jr,. Predicting hospital mortality in critically ill cancer patients according to acute kidney injury severity. Oncology. 2011; 80 (3–4): 160 – 166
164. Lombardi R, Nin N, Lorente JA,; VENTILA Group. An assessment of the Acute Kidney Injury Network creatinine-based criteria in patients submitted to mechanical ventilation. Clin J Am Soc Nephrol. 2011; 6 (7): 1547 – 1555
165. Maioli M, Toso A, Leoncini M, Micheletti C, Bellandi F. Effects of hydration in contrast-induced acute kidney injury after primary angioplasty: a randomized, controlled trial. Circ Cardiovasc Interv. 2011; 4 (5): 456 – 462
166. Ostermann M, Chang RW. Impact of different types of organ failure on outcome in intensive care unit patients with acute kidney injury. J Crit Care. 2011; 26 (6): 635, e1–e5, e10
167. Patel UD, Garg AX, Krumholz HM,; Translational Research Investigating Biomarker Endpoints in Acute Kidney Injury (TRIBE-AKI) Consortium. Preoperative serum brain natriuretic peptide and risk of acute kidney injury after cardiac surgery. Circulation. 2012; 125 (11): 1347 – 1355
168. Pettilä V, Webb SA, Bailey M, Howe B, Seppelt IM, Bellomo R. Acute kidney injury inpatients with influenza A(H1N1) 2009. Intensive Care Med. 2011; 37 (5): 763 – 767
169. Piccinni P, Cruz DN, Gramaticopolo S,; NEFROINT Investigators. Prospective multicenter study on epidemiology of acute kidney injury in the ICU: a critical care nephrology Italian collaborative effort (NEFROINT). Minerva Anestesiol. 2011; 77 (11): 1072 – 1083
170. Tiranathanagul K, Jearnsujitwimol O, Susantitaphong P,. Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration. Ther Apher Dial. 2011; 15 (6): 556 – 564
171. Zappitelli M, Krawczeski CD, Devarajan P,; TRIBE-AKI Consortium. Early postoperative serum cystatin C predicts severe acute kidney injury following pediatric cardiac surgery. Kidney Int. 2011; 80 (6): 655 – 662
172. Koyner JL, Bennett MR, Worcester EM,. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int. 2008; 74 (8): 1059 – 1069
173. Bellomo, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative Workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004; 8 (4): R204 – R212
174. Di Grande A, Giuffrida C, Carpinteri G,. Neutrophil gelatinase-associated lipocalin: a novel biomarker for the early diagnosis of acute kidney injury in the emergency department. Eur Rev Med Pharmacol Sci. 2009; 13 (3): 197 – 200
175. Preda L, Agazzi A, Raimondi S,. Effect on renal function of an iso-osmolar contrast agent in patients with monoclonal gammopathies. Eur Radiol. 2011; 21 (1): 63 – 69
176. McCullough PA, Sandberg KR. Epidemiology of contrast-induced nephropathy. Rev Cardiovasc Med. 2003;(4 suppl 5): S3 – S9
177. Garni AS, Garovic VD. Contrast nephropathy after coronary angiography [published correction appears in Mayo Clin Proc. 2004;79(3):432. Dosage error in article text]. Mayo Clin Proc. 2004; 79 (2): 211 – 219
178. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002; 39 (5): 930 – 936
179. Marenzi G, Lauri G, Assanelli E,. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2004; 44 (9): 1780 – 1785
180. Awal A, Ahsan SA, Siddique MA,. Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention. Mymensingh Med J. 2011; 20 (2): 264 – 269
181. Bosso JA, Nappi J, Rudisill C,. Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial. Antimicrob Agents Chemother. 2011; 55 (12): 5475 – 5479
182. Camilla R, Suzuki H, Daprà V,. Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy. Clin J Am Soc Nephrol. 2011; 6 (8): 1903 – 1911
183. Cass RT, Brooks CD, Havrilla NA,. Pharmacokinetics and safety of single and multiple doses of ACHN-490 injection administered intravenously in healthy subjects. Antimicrob Agents Chemother. 2011; 55 (12): 5874 – 5880
184. Cox ZL, Nelsen CL, Waitman LR, McCoy JA, Peterson JF. Effects of clinical decision support on initial dosing and monitoring of tobramycin and amikacin. Am J Health Syst Pharm. 2011; 68 (7): 624 – 632
185. Ekberg H, van Gelder T, Kaplan B, Bernasconi C. Relationship of tacrolimus exposure and mycophenolate mofetil dose with renal function after renal transplantation. Transplantation. 2011; 92 (1): 82 – 87
186. Farhat FS, Temraz S, Kattan J,. A phase II study of lipoplatin (liposomal cisplatin)/vinorelbine combination in HER-2/neu-negative metastatic breast cancer. Clin Breast Cancer. 2011; 11 (6): 384 – 389
187. Gálvez R, Luengo C, Cornejo R,. Higher than recommended amikacin loading doses achieve pharmacokinetic targets without associated toxicity. Int J Antimicrob Agents. 2011; 38 (2): 146 – 151
188. Giovacchini G, Nicolas G, Freidank H, Mindt TL, Forrer F. Effect of amino acid infusion on potassium serum levels in neuroendocrine tumour patients treated with targeted radiopeptide therapy. Eur J Nucl Med Mol Imaging. 2011; 38 (9): 1675 – 1682
189. Gonzalez D, García CD, Azócar M,. Growth of kidney-transplanted pediatric patients treated with sirolimus. Pediatr Nephrol. 2011; 26 (6): 961 – 966
190. Hanly LN, Chen N, Aleksa K,. N-acetylcysteine as a novel prophylactic treatment for ifosfamide-induced nephrotoxicity in children: translational pharmacokinetics. J Clin Pharmacol. 2012; 52 (1): 55 – 64
191. Heilman RL, Younan K, Wadei HM,. Results of a prospective randomized trial of sirolimus conversion in kidney transplant recipients on early corticosteroid withdrawal. Transplantation. 2011; 92 (7): 767 – 773
192. Jacobson PA, Schladt D, Israni A,; DeKAF Investigators. Genetic and clinical determinants of early, acute calcineurin inhibitor-related nephrotoxicity: results from a kidney transplant consortium. Transplantation. 2012; 93 (6): 624 – 631
193. Kullar R, Leonard SN, Davis SL,. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15–20 mg/L suggested by the vancomycin consensus guidelines. Pharmacotherapy. 2011; 31 (5): 441 – 448
194. Kurtz JE, Freyer G, Joly F,; GINECO Group, France. Combined oral topotecan plus carboplatin in relapsed or advanced cervical cancer: a GINECO phase I-II trial. Anticancer Res. 2012; 32 (3): 1045 – 1049
195. Ludwig U, Riedel MK, Backes M, Imhof A, Muche R, Keller F. MESNA (sodium 2-mercaptoethanesulfonate) for prevention of contrast medium-induced nephrotoxicity - controlled trial. Clin Nephrol. 2011; 75 (4): 302 – 308
196. Manito N, Rábago G, Palomo J,. Improvement in chronic renal failure after mycophenolate mofetil introduction and cyclosporine dose reduction: four-year results from a cohort of heart transplant recipients. Transplant Proc. 2011; 43 (7): 2699 – 2706
197. Manolakopoulos S, Striki A, Deutsch M,. Long-term adefovir plus lamivudine therapy does not decrease creatinine clearance in HBeAg-negative chronic hepatitis B patients. Liver Int. 2011; 31 (10): 1525 – 1532
198. Sabry NA, Habib EE. Zoledronic acid and clodronate in the treatment of malignant bone metastases with hypercalcaemia; efficacy and safety comparative study. Med Oncol. 2011; 28 (2): 584 – 590
199. Sato S, Fujiwara H, Oishi T,. Evaluation of a formula for individual dosage of nedaplatin based on renal function. Cancer Chemother Pharmacol. 2012; 69 (3): 599 – 603
200. Schmeding M, Kiessling A, Neuhaus R,. Mycophenolate mofetil monotherapy in liver transplantation: 5-year follow-up of a prospective randomized trial. Transplantation. 2011; 92 (8): 923 – 929
201. Shin DH, Choi DJ, Youn TJ,. Comparison of contrast-induced nephrotoxicity of iodixanol and iopromide in patients with renal insufficiency undergoing coronary angiography. Am J Cardiol. 2011; 108 (2): 189 – 194
202. Stathopoulos GP, Antoniou D, Dimitroulis J, Stathopoulos J, Marosis K, Michalopoulou P. Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer. Cancer Chemother Pharmacol. 2011; 68 (4): 945 – 950
203. Zengin E, Sarper N, Kihç SC. Piperacillin/tazobactam monotherapy versus piperacillin/tazobactam plus amikacin as initial empirical therapy for febrile neutropenia in children with acute leukemia. Pediatr Hematol Oncol. 2011; 28 (4): 311 – 320
204. Murugan R, Kellum JA. Acute kidney injury: what's the prognosis? Nat Rev Nephrol. 2011; 7 (4): 209 – 217